Business context and reporting period
Nexalin Technology, Inc. (Nasdaq: NXL) filed this Form 8-K regarding a September 25, 2026 Nasdaq Hearings Panel decision on the company’s continued listing. The report was signed September 28, 2026.
Financial and operating information
This filing does not report revenue, profit, cash flow, margins, debt, or liquidity figures. It states that continued listing requires stockholders’ equity of at least $2.5 million.
Material developments
- The Panel granted Nexalin’s request to remain listed on The Nasdaq Capital Market, subject to specified compliance conditions.
- By September 28, 2026, the company must demonstrate compliance with Nasdaq’s minimum bid price requirement, including a closing bid price of at least $1.00 per share for 20 consecutive trading sessions.
- By January 4, 2027, the company must demonstrate compliance with the $2.5 million minimum stockholders’ equity requirement.
- The company’s shares will continue trading during the exception period, subject to compliance with the Panel’s conditions.
Outlook, risks, and contingencies
Nexalin said it intends to take the steps needed to satisfy the conditions. The company cautioned that it cannot assure compliance with either requirement or continued compliance with other Nasdaq listing standards. Failure to meet the Panel’s conditions could result in delisting.
The decision follows a July 24, 2026 Nasdaq notice that Nexalin had not regained minimum bid price compliance and was ineligible for an additional compliance period because it did not meet the $5 million minimum stockholders’ equity initial-listing requirement. An August 17, 2026 notice stated that the company failed the continued-listing equity requirement and both alternative standards.
Key facts for investors to verify
- Whether Nasdaq confirmed minimum bid price compliance by September 28, 2026, including the required 20 consecutive sessions at or above $1.00.
- Whether Nexalin met the $2.5 million stockholders’ equity requirement by January 4, 2027.
- Any subsequent Nasdaq notice, compliance-period update, or delisting determination.